SK Capital is set to acquire Canadian generics giant Apotex, with the private investment firm promising “support Apotex’s next phase of growth and continued innovation for patient affordability.”
Canada’s Apotex Is Snapped Up By SK Capital
Canadian Generics Giant Acquired By Private Investment Firm
Apotex is to be acquired by SK Capital, the private investment firm has announced. The Canadian generics giant’s new owner has promised to invest in the firm to “support Apotex’s next phase of growth and continued innovation for patient affordability.”
